Introduction:
The regulations controlling the use of and prescription practices for controlled substances and
narcotics differ from nation to nation and are susceptible to change at any time. Controlled
substances are usually subject to regulations because of the possibility of misuse or injury. If
you have any issues concerning a specific prohibited substance, it's vital to refer to the
individual rules and regulations of your jurisdiction. For example, in the United States, the Drug
Enforcement Administration (DEA) is responsible for regulating the prescription of controlled
substances.
Controlled drugs are substances, items, or preparations (including some medications) that are
either known to be hazardous or destructive to human health, including having the potential to
be abused or harm society.
Differentiating between a lawful prescription for a controlled substance and one that might be
used illegally is one of the hardest tasks facing any medical professional. Prescribers must be
knowledgeable of both the indications and symptoms of patients abusing controlled substances
as well as the signs, symptoms, and treatment of both acute and chronic pain in order to make
the appropriate decisions. The following are some typical factors to take into account: patient
assessment, record-keeping, informed agreement, monitoring, and evaluation; length of
prescription; avoiding drug combinations; education; and state and federal restrictions. Keep in
mind that these are only recommendations and could not apply to all particular circumstances.
It is imperative that healthcare providers be up-to-date on the most recent guidelines and
regulations pertaining to their specific jurisdictions.
When prescribing opioid analgesics, all medical professionals involved in pain management
need to be aware of the safety risks and recommended courses of action. The 1990s saw an
increase in the prescription of opioid analgesics as a result of medical practitioners' ongoing
inability to adequately treat severe pain. Regretfully, this resulted in a rise in drug abuse, drug
diversion, opioid use disorder, and overdose.
1. Kaldy J. Controlled Substances Add New Layer to E-Prescribing. Consult Pharm. 2016 Apr;31(4):200-6.
2. Jayawant SS, Balkrishnan R. The controversy surrounding OxyContin abuse: issues and solutions. Ther
Clin Risk Manag. 2005 Jun;1(2):77-82.
[Link]
Conclusion :
Efficient prescription of opioids requires a thorough assessment of the patient, diligent
monitoring, long- and short-term treatment planning, and follow-up. Since opioids are
regulated medications, healthcare providers should always prescribe and dispense them in
accordance with best practices and guidelines. Patient evaluation, classification and scheduling,
prescription requirements, looking into non-opioid alternatives, dispensing and distribution,
patient information, storage and security, reporting and monitoring, penalties for violations,
and treatment agreements should be upheld are all covered by the laws pertaining to
prescribing guidelines and the use of controlled drugs.
Prescriptions for opioid analgesics should only be written for a short time, usually a few days to
three or four weeks. Due to a lack of awareness, clinicians frequently misidentify a patient with
chronic non-use disorder as someone who is abusing their prescribed opioid. Thus, a typical
worry among patients is the efficiency with which the medical professional manages their pain.
Physicians, nurses, pharmacists, and other members of the healthcare team must collaborate in
order to properly diagnose, treat, and prevent addiction in patients with pain. To achieve the
intended effect, efficacy, and tolerability, the prescriber should always start therapy at the
lowest possible dose and then progressively increase the dose and frequency. The physician
should make sure the patient is aware of the necessity of routine monitoring and frequent
evaluation of the advantages and disadvantages of the prescribed course of action.
Complications include diarrhea, exhaustion, nausea, and the possibility of respiratory
depression should be discussed with the patient.
3. Clinton HA, Hunter AA, Logan SB, Lapidus GD. Evaluating opioid overdose using the National Violent
Death Reporting System, 2016. Drug Alcohol Depend. 2019 Jan 01;194:371-376.
4. Rose AJ, McBain R, Schuler MS, LaRochelle MR, Ganz DA, Kilambi V, Stein BD, Bernson D, Chui KKH,
Land T, Walley AY, Stopka TJ. Effect of Age on Opioid Prescribing, Overdose, and Mortality in
Massachusetts, 2011 to 2015. J Am Geriatr Soc. 2019 Jan;67(1):128-132.
[Link]